Andrew Craig
Research Subjects
Andrew Craig has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- John F. McDyer
University of Pittsburgh Division of Pulmonary, Allergy, Critical Care and Sleep Medicine; University of Pittsburgh Lung Transplant Research Center
2 shared publications - Mark E. Snyder
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center
2 shared publications - Anna Bondonese
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine , Pittsburgh, PA
1 shared publication - Bruce Johnson
Department of Medicine, University of Pittsburgh, Pittsburgh, PA 1
1 shared publication - Byron Chuan
Department of Medicine
1 shared publication - Daniel J. Kass
University of Pittsburgh
1 shared publication
Latest Publications
- Open Access
- 7 January 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (4)
NKG2D blockade impairs tissue-resident memory T cell accumulation and reduces chronic lung allograft dysfunction
Chronic lung allograft dysfunction (CLAD) substantially limits long-term survival following lung transplantation. To identify potential targets for CLAD prevention, T cells from explanted CLAD lungs and lung-draining lymph nodes, as well as diseased and nondiseased controls were isolated and single-cell RNA sequencing and TCR sequencing were performed. TCR sequencing revealed a clonally expanded population of CD8 + tissue-resident memory T cells (TRMs) with high cytotoxic potential, including upregulation of KLRK1 , encoding the co-receptor NKG2D. These cytotoxic CD8 + TRMs accumulated around the CLAD airways and had a 100-fold increase in clonal overlap with lung-draining lymph nodes when compared with non-CLAD lungs. Using a murine model of orthotopic lung transplantation, we confirmed that cytotoxic CD8 + TRM accumulation was due to chronic rejection and not transplantation alone. Furthermore, blocking NKG2D in vivo attenuated the airway remodeling following transplantation and diminished airway accumulation of CD8 + T cells. Our findings support NKG2D as a potential therapeutic target for CLAD, affecting cytotoxic CD8 + TRM accumulation.
- 7 January 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (4)
Open AccessNKG2D blockade impairs tissue-resident memory T cell accumulation and reduces chronic lung allograft dysfunction
Chronic lung allograft dysfunction (CLAD) substantially limits long-term survival following lung transplantation. To identify potential targets for CLAD prevention, T cells from explanted CLAD lungs and lung-draining lymph nodes, as well as diseased and nondiseased controls were isolated and single-cell RNA sequencing and TCR sequencing were performed. TCR sequencing revealed a clonally expanded population of CD8 + tissue-resident memory T cells (TRMs) with high cytotoxic potential, including upregulation of KLRK1 , encoding the co-receptor NKG2D. These cytotoxic CD8 + TRMs accumulated around the CLAD airways and had a 100-fold increase in clonal overlap with lung-draining lymph nodes when compared with non-CLAD lungs. Using a murine model of orthotopic lung transplantation, we confirmed that cytotoxic CD8 + TRM accumulation was due to chronic rejection and not transplantation alone. Furthermore, blocking NKG2D in vivo attenuated the airway remodeling following transplantation and diminished airway accumulation of CD8 + T cells. Our findings support NKG2D as a potential therapeutic target for CLAD, affecting cytotoxic CD8 + TRM accumulation.
- Open Access
- 14 March 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (4)
Modulation of tissue resident memory T cells by glucocorticoids after acute cellular rejection in lung transplantation
Acute cellular rejection is common after lung transplantation and is associated with an increased risk of early chronic rejection. We present combined single-cell RNA and TCR sequencing on recipient-derived T cells obtained from the bronchoalveolar lavage of three lung transplant recipients with rejection and compare them with T cells obtained from the same patients after treatment of rejection with high-dose systemic glucocorticoids. At the time of rejection, we found an oligoclonal expansion of cytotoxic CD8+ T cells that all persisted as tissue resident memory T cells after successful treatment. Persisting CD8+ allograft-resident T cells have reduced gene expression for cytotoxic mediators after therapy with glucocorticoids but accumulate around airways. This clonal expansion is discordant with circulating T cell clonal expansion at the time of rejection, suggesting in situ expansion. We thus highlight the accumulation of cytotoxic, recipient-derived tissue resident memory T cells within the lung allograft that persist despite the administration of high-dose systemic glucocorticoids. The long-term clinical consequences of this persistence have yet to be characterized.
- 14 March 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (4)
Open AccessModulation of tissue resident memory T cells by glucocorticoids after acute cellular rejection in lung transplantation
Acute cellular rejection is common after lung transplantation and is associated with an increased risk of early chronic rejection. We present combined single-cell RNA and TCR sequencing on recipient-derived T cells obtained from the bronchoalveolar lavage of three lung transplant recipients with rejection and compare them with T cells obtained from the same patients after treatment of rejection with high-dose systemic glucocorticoids. At the time of rejection, we found an oligoclonal expansion of cytotoxic CD8+ T cells that all persisted as tissue resident memory T cells after successful treatment. Persisting CD8+ allograft-resident T cells have reduced gene expression for cytotoxic mediators after therapy with glucocorticoids but accumulate around airways. This clonal expansion is discordant with circulating T cell clonal expansion at the time of rejection, suggesting in situ expansion. We thus highlight the accumulation of cytotoxic, recipient-derived tissue resident memory T cells within the lung allograft that persist despite the administration of high-dose systemic glucocorticoids. The long-term clinical consequences of this persistence have yet to be characterized.